Improved depressive symptoms, and emotional regulation and reactivity, in individuals with obstructive sleep apnea after short- and long-term CPAP therapy use.

Continuous positive airway pressure Depression Emotion Sleep Sleepiness

Journal

Sleep medicine
ISSN: 1878-5506
Titre abrégé: Sleep Med
Pays: Netherlands
ID NLM: 100898759

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 20 03 2023
revised: 14 08 2023
accepted: 27 08 2023
pubmed: 16 9 2023
medline: 16 9 2023
entrez: 15 9 2023
Statut: ppublish

Résumé

Obstructive Sleep Apnoea (OSA) is associated with high rates of depression; however, if and how treatment of OSA improves depressive symptoms is unclear. To further understand this link we considered the role of emotional regulation - the ability to control and express our emotional responses - thought to be a central component of depression. This study aimed to assess changes in depressive symptoms and emotional responses in individuals with OSA after 4- and 12-months of continuous positive airway pressure (CPAP) treatment. One-hundred and twenty-one OSA participants (50 female, M

Identifiants

pubmed: 37714031
pii: S1389-9457(23)00314-3
doi: 10.1016/j.sleep.2023.08.024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-20

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest CPAP devices were provided by Air Liquide. Air Liquide had no role in study design, analysis or manuscript preparation. The authors have no other conflict of interest to declare.

Auteurs

Emily Pattison (E)

Institute for Breathing and Sleep, Austin Health, Heidelberg, Melbourne, Australia; RMIT University, School of Health and Biomedical Science, Melbourne, Australia.

Julie Tolson (J)

Institute for Breathing and Sleep, Austin Health, Heidelberg, Melbourne, Australia.

Maree Barnes (M)

Institute for Breathing and Sleep, Austin Health, Heidelberg, Melbourne, Australia; The University of Melbourne, Melbourne, Australia.

William J Saunders (WJ)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia.

Delwyn Bartlett (D)

Woolcock Institute for Medical Research, & the University of Sydney, NSW, Australia.

Luke A Downey (LA)

Institute for Breathing and Sleep, Austin Health, Heidelberg, Melbourne, Australia; Centre for Human Psychopharmacology, Swinburne University, Hawthorn, Melbourne, Australia.

Melinda L Jackson (ML)

Institute for Breathing and Sleep, Austin Health, Heidelberg, Melbourne, Australia; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Melbourne, Australia. Electronic address: melinda.jackson@monash.edu.

Classifications MeSH